查詢結果分析
相關文獻
- Efficacy and Safety of Nifelan in Patients with Mild to Moderate Hypertension
- AROTINOLOL治療原發性高血壓的臨床研究
- 運動對高血壓的影響
- Unexpected Pheochromocytoma--A Case Report of Anesthesia in a Uremic Patient
- Relationship between Microalbuminuria, Left Ventricular Mass and Function in Essential Hypertension
- The Effect of Sphenopalatine Postganglionic Neurotomy on the Alteration of Local Cerebral Blood Flow of Normotensive and Hypertensive Rats in Acute Cold Stress
- 衛生教育對於榮民之家高血壓老人自我照顧行為與血壓控制之影響
- 長期阻斷內生性一氧化氮對血壓的影響:正常鼠與高血壓鼠間的比較
- Comparison of Clinical Efficacy and Adverse Effects between Extended-release Felodipine and Slow-release Diltiazem in Patients with Isolated Systolic Hypertension
- 同時多發性高血壓腦出血--病例報告
頁籤選單縮合
題 名 | Efficacy and Safety of Nifelan in Patients with Mild to Moderate Hypertension=Nifelan對輕度至中度高血壓病人的治療效果 |
---|---|
作 者 | 曾春典; 江福田; 許寬立; 駱惠銘; 曾淵如; | 書刊名 | Acta Cardiologica Sinica |
卷 期 | 14:1 民87.01-03 |
頁 次 | 頁9-15 |
分類號 | 418.221 |
關鍵詞 | 高血壓; 24小時血壓記錄; 隨機血壓; Hypertension; Ambulatory blood pressure monitoring; Casual BP; Nifelan; |
語 文 | 英文(English) |
中文摘要 | 背景:長效緩釋型nifedipine (Nifelan 20mg)對中國人患高血壓者的效果未曾有人報告。本文的目的在探討(Nifelan)對中國人輕到中度高血壓病人有效性和安全性。 材料與方法:全部40位病人投與此一天一次劑型(Nifelan 20mg)和另一中長效nifedipine 劑型(Adalat Retard 20mg)的藥效做比較。 在Nifelan和Adalat Retard的投藥前和投藥後分別測定坐姿血壓、心跳、血球數、尿液分析、生化檢查值,ECG和24小時血壓監視(ABPM,僅20例完成三次記錄)。於每次病人門診亦分別記錄副作用。 結果與結論:我們發現兩藥有相似的治療效果。Nifelan與Adalat Retard在臨床試用期間無論白天或晚上均可有效下降隨機血壓和24小時血壓,也均會上升隨機心跳,但不會影響24小時心跳。大約12.5到15%病人在藥物投與期間有輕微或暫時性的副作用出現,包括頭痛、臉紅、便秘、四肢麻木和腳水腫等,且兩藥之間無顯著差異。基於以上觀察,我們結論Nifelan一天一次為一有效且安全的藥物,適合中國人輕到中度的高血壓病人使用。 |
英文摘要 | Background. The anti-hypertensive effect of slow released nifedipine [Nifelan(r)20mg] in Chinese patient has not been reported. This study is attempt to investigate the clinical efficacy and safety of Nifelan in Chinese patients with mild to moderate hypertension. Materials and methods. A total of 40 patients who were on this once-daily regimen were observed and compared with the effect of an intermediate form of nifedipine [Adalat Retard 20mg]. Before and after treatment with either Nifelan or Adalat Retard, sitting blood pressure (BP), heart rate (HR), blood cell count, urinalysis, biochemical profile, ECG and ambulatory blood pressure monitoring (ABPM, in 20 patients only) were examined. Side effects were also recorded at each visit. Results and conclusion. We found that Nifelan and Adalat Retard could significantly reduce the causal BP and ambulatory BP averages during the whole day, the daytime and the nighttime periods. Both drugs increased the causal heart rate but not the ambulatory heart rate. These effects were similar between Nifelan and Adalat Retard treatment. About 12.5 to 15% developed mild and transient side effects including headache, flushing of face, constipation, numbness of digits and leg edema during taking either drug. Based on these observations, we conclude that Nifelan once daily is an effective and safe regimen for the treatment of Chinese patients with mild to moderate hyperension. |
本系統中英文摘要資訊取自各篇刊載內容。